Effects of Intensive Systolic Blood Pressure Control on Glycometabolic and Cardiovascular Outcomes in Normoglycemic Patients: A Secondary Analysis of a Randomized Trial

Cheng Yang; Wei-Hua Chen; Jie Qian; Rong-Chong Huang; Jian-Jun Li

doi:10.1002/mco2.70197

MedComm ›› 2025, Vol. 6 ›› Issue (5) : e70197 DOI: 10.1002/mco2.70197

LETTER

Effects of Intensive Systolic Blood Pressure Control on Glycometabolic and Cardiovascular Outcomes in Normoglycemic Patients: A Secondary Analysis of a Randomized Trial

Author information +

History +

PDF

Cite this article

Download citation ▾

Cheng Yang, Wei-Hua Chen, Jie Qian, Rong-Chong Huang, Jian-Jun Li. Effects of Intensive Systolic Blood Pressure Control on Glycometabolic and Cardiovascular Outcomes in Normoglycemic Patients: A Secondary Analysis of a Randomized Trial. MedComm, 2025, 6(5): e70197 DOI:10.1002/mco2.70197

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	K. Khunti, Y. V. Chudasama, E. W. Gregg, et al., “Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge,” Diabetes Care 46, no. 12 (2023): 2092-2101.

[2]	M. J. O'Brien, J. Y. Lee, M. R. Carnethon, et al., “Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients,” PLoS Medicine 13, no. 7 (2016): e1002074.

[3]	L. Lauder, F. Mahfoud, M. Azizi, et al., “Hypertension Management in Patients With Cardiovascular Comorbidities,” European Heart Journal 44, no. 23 (2023): 2066-2077.

[4]	R. Yang, Y. Zhu, M. Xu, Y. Tao, W. Cong, and J. Cai, “Intensive Blood Pressure Lowering and the Risk of New-Onset Diabetes in Patients with Hypertension: A Post-Hoc Analysis of the STEP Randomized Trial,” European Journal of Preventive Cardiology 30, no. 10 (2023): 988-995.

[5]	C. L. Roumie, A. M. Hung, G. B. Russell, et al., “Blood Pressure Control and the Association With Diabetes Mellitus Incidence: Results From SPRINT Randomized Trial,” Hypertension 75, no. 2 (2020): 331-338.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.